TP53 and hepatocellular carcinoma: In terms of the alpha diversity, we observed significant associations between alpha diversity and TP53 mutation in PAAD, LUAD, EC and HCC (Figure 3c,e,h and j), supported by at least three alpha diversity indices in each of the three cancer types.